Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes
- PMID: 1655814
- PMCID: PMC2289173
- DOI: 10.1083/jcb.115.3.851
Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes
Abstract
We have previously reported on the dependency of activated B lymphocytes for retinol. Here we confirm and extend these findings that cells deprived of retinol perish in cell culture within days, displaying neither signs of apoptosis nor of cell cycle arrest. Cell death can be prevented by physiological concentrations of retinol and retinal, but not by retinoic acid or three synthetic retinoic acid analogues. To exclude the possibility that retinoic acid is so rapidly degraded as to escape detection, we have tested its stability in intra- and extracellular compartments. Contrary to expectation, we find that retinoic acid persists for longer (t 1/2 3 d) in cultures than retinol (t 1/2 1 d). Furthermore, despite the use of sensitive trace-labeling techniques, we cannot detect retinoic acid or 3,4-didehydroretinoic acid among retinol metabolites. However, retinol is converted into several new retinoids, one of which has the ability to sustain B cell growth in the absence of an external source of retinol, supporting the notion of a second retinol pathway. We have also determined which of the known retinoid-binding proteins are expressed in B lymphoblastoid cells. According to results obtained with polymerase chain reaction-assisted mRNA detection, they transcribe the genes for cellular retinol- and cellular retinoic acid-binding proteins, for the nuclear retinoic acid receptors, RAR-alpha, -gamma, and RXR-alpha, but not RAR-beta. Our findings that B cells do not synthesize retinoic acid or respond to exogenous retinoic acid on the one hand, but on the other hand convert retinol to a novel bioactive form of retinol, suggest the existence of a second retinoid pathway, distinct from that of retinoic acids.
Similar articles
-
Retinoid pathway and cancer therapeutics.Adv Drug Deliv Rev. 2010 Oct 30;62(13):1285-98. doi: 10.1016/j.addr.2010.07.003. Epub 2010 Aug 3. Adv Drug Deliv Rev. 2010. PMID: 20654663 Free PMC article. Review.
-
Molecular and metabolic retinoid pathways in the human ocular surface.Mol Vis. 2007 Sep 11;13:1641-50. Mol Vis. 2007. PMID: 17893666
-
Expression of epithelial markers and retinoid-binding proteins in retinol- or retinoic acid-treated intestinal cells in vitro.Exp Cell Res. 1993 Sep;208(1):137-47. doi: 10.1006/excr.1993.1231. Exp Cell Res. 1993. PMID: 8395395
-
Increased levels of several retinoid binding proteins resulting from retinoic acid-induced differentiation of F9 cells.Cancer Res. 1986 Feb;46(2):717-22. Cancer Res. 1986. PMID: 3000582
-
[Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].Bull Cancer. 1992;79(7):697-704. Bull Cancer. 1992. PMID: 1334741 Review. French.
Cited by
-
Multi-dimensional computational pipeline for large-scale deep screening of compound effect assessment: an in silico case study on ageing-related compounds.NPJ Syst Biol Appl. 2019 Nov 26;5:42. doi: 10.1038/s41540-019-0119-y. eCollection 2019. NPJ Syst Biol Appl. 2019. PMID: 31798962 Free PMC article.
-
Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives.Biochim Biophys Acta. 2012 Jan;1821(1):99-112. doi: 10.1016/j.bbalip.2011.06.010. Epub 2011 Jun 17. Biochim Biophys Acta. 2012. PMID: 21704730 Free PMC article. Review.
-
Techniques to study specific cell-surface receptor-mediated cellular vitamin A uptake.Methods Mol Biol. 2010;652:341-61. doi: 10.1007/978-1-60327-325-1_20. Methods Mol Biol. 2010. PMID: 20552439 Free PMC article.
-
Retinol supplements antiviral action of interferon in patients with chronic hepatitis C: a prospective pilot study.J Clin Biochem Nutr. 2010 Jan;46(1):36-42. doi: 10.3164/jcbn.09-48. Epub 2009 Dec 29. J Clin Biochem Nutr. 2010. PMID: 20104263 Free PMC article.
-
Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.J Immunol. 2009 Dec 1;183(11):6903-12. doi: 10.4049/jimmunol.0900324. Epub 2009 Nov 13. J Immunol. 2009. PMID: 19915048 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical